Aradigm Corp. Company Profile (NASDAQ:ARDM)

About Aradigm Corp.

Aradigm Corp. logoAradigm Corporation is a pharmaceutical company. The Company is focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin, which is in Phase III clinical trials. The Company also invested on AERx pulmonary drug delivery platform and other technologies. The Company's partnered programs under development include Inhaled Ciprofloxacin. The Company is also developing Smoking Cessation Therapy (ARD-1600 Inhaled Nicotine) program. Its lead development candidates are the Company's formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100)) that are delivered by inhalation for the management of infections associated with severe respiratory diseases, such as non-cystic fibrosis bronchiectasis (BE) and cystic fibrosis (CF).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ARDM
  • CUSIP:
Key Metrics:
  • Previous Close: $4.74
  • 50 Day Moving Average: $4.671
  • 200 Day Moving Average: $4.272
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: Infinity
  • P/E Growth: 0.000
  • Market Cap: $69.31M
  • Outstanding Shares: 14,781,000
  • Beta: 0.99
Additional Links:
Companies Related to Aradigm Corp.:

Analyst Ratings

Consensus Ratings for Aradigm Corp. (NASDAQ:ARDM) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Aradigm Corp. (NASDAQ:ARDM)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Aradigm Corp. (NASDAQ:ARDM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016        
8/10/2016Q2($0.59)($0.59)ViewN/AView Earnings Details
5/10/2016Q1($0.59)($0.55)ViewN/AView Earnings Details
3/15/2016Q415($0.55)($0.63)ViewN/AView Earnings Details
11/11/2015Q3($0.19)($0.38)ViewN/AView Earnings Details
8/13/2015Q2($0.08)($0.08)$11.60 million$10.00 millionViewN/AView Earnings Details
5/11/2015Q1($0.06)($0.08)ViewN/AView Earnings Details
3/17/2015Q414($0.07)($0.06)$6.70 million$8.10 millionViewN/AView Earnings Details
11/7/2014Q314($0.10)($0.06)$4.80 million$6.60 millionViewN/AView Earnings Details
8/7/2014Q214($0.09)($0.09)$4.25 million$12.20 millionViewN/AView Earnings Details
10/28/2013Q3 13($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aradigm Corp. (NASDAQ:ARDM)
Current Year EPS Consensus Estimate: $-1.92 EPS

Dividends

Dividend History for Aradigm Corp. (NASDAQ:ARDM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aradigm Corp. (NASDAQ:ARDM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2016Juergen Kurt FroehlichInsiderSell333$4.45$1,481.85View SEC Filing  
12/13/2013Virgil ThompsonDirectorSell3,340$0.17$567.80View SEC Filing  
8/27/2013First Eagle Investment ManagemMajor ShareholderBuy40,322,580$0.12$4,838,709.60View SEC Filing  
12/11/2012First Eagle Investment ManagemMajor ShareholderBuy41,666,667$0.12$5,000,000.04View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aradigm Corp. (NASDAQ:ARDM)
DateHeadline
capitalcube.com logoAradigm Corp. :ARDM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ARDM)
www.capitalcube.com - August 12 at 12:07 PM
sg.finance.yahoo.com logoAradigm reports 2Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - August 10 at 9:40 AM
publicnow.com logoAradigm Announces Second Quarter 2016 Financial Results (NASDAQ:ARDM)
www.publicnow.com - August 10 at 9:40 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:ARDM)
biz.yahoo.com - June 10 at 5:02 PM
capitalcube.com logoAradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:ARDM)
www.capitalcube.com - May 17 at 12:15 PM
publicnow.com logoTwo Presentations on Aradigm's Inhaled Liposomal Ciprofloxacin Programs at the American Thoracic Society 2016 International Conference (NASDAQ:ARDM)
www.publicnow.com - May 11 at 7:22 AM
finance.yahoo.com logoTwo Presentations on Aradigm’s Inhaled Liposomal Ciprofloxacin Programs at the American Thoracic Society 2016 International Conference (NASDAQ:ARDM)
finance.yahoo.com - May 11 at 7:00 AM
sg.finance.yahoo.com logoAradigm reports 1Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - May 10 at 9:03 AM
publicnow.com logoAradigm Announces First Quarter 2016 Financial Results (NASDAQ:ARDM)
www.publicnow.com - May 10 at 7:08 AM
insidermonkey.com logoActivist Starboard Value Gets Seats on Marvell Technology Group Ltd. (MRVL)’s Board; Two Other Hedge Funds Disclose Latest Moves (NASDAQ:ARDM)
www.insidermonkey.com - April 29 at 9:42 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:ARDM)
biz.yahoo.com - April 28 at 4:08 PM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio (NASDAQ:ARDM)
biz.yahoo.com - April 27 at 4:30 PM
publicnow.com logoAradigm Corporation Announces First Closing of Private Placement Offering of $23 Million Senior Convertible Notes Due 2021 (NASDAQ:ARDM)
www.publicnow.com - April 26 at 7:26 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:ARDM)
biz.yahoo.com - April 25 at 12:08 PM
proactiveinvestors.co.uk logoSlew of results disappointments hamstring S&P (NASDAQ:ARDM)
www.proactiveinvestors.co.uk - April 23 at 6:45 AM
publicnow.com logoAradigm Corporation Prices Private Placement of Senior Notes (NASDAQ:ARDM)
www.publicnow.com - April 22 at 8:36 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 10-K, Annual Report (NASDAQ:ARDM)
biz.yahoo.com - March 30 at 2:33 PM
finance.yahoo.com logo7:00 am Aradigm announces that the EMA has approved its request to review Pulmaquin under the Centralised Authorisation Procedure drug review process (NASDAQ:ARDM)
finance.yahoo.com - March 17 at 7:00 AM
finance.yahoo.com logoAradigm Announces Decision for Centralized Review of Pulmaquin by the European Medicines Agency (NASDAQ:ARDM)
finance.yahoo.com - March 17 at 7:00 AM
sg.finance.yahoo.com logoAradigm reports 4Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - March 15 at 7:13 AM
finance.yahoo.com logoAradigm Announces Fourth Quarter 2015 and Full Year Financial Results (NASDAQ:ARDM)
finance.yahoo.com - March 15 at 7:00 AM
finance.yahoo.com logoAradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2016 on February 8 (NASDAQ:ARDM)
finance.yahoo.com - February 2 at 7:00 AM
noodls.com logoAradigm to Host Corporate Update Conference Call on January 6 (NASDAQ:ARDM)
www.noodls.com - January 5 at 7:28 AM
capitalcube.com logoAradigm Corp.: Sudden move in price, will it continue? (NASDAQ:ARDM)
www.capitalcube.com - December 23 at 5:16 PM
capitalcube.com logoAradigm Corp. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:ARDM)
www.capitalcube.com - December 21 at 12:11 PM
finance.yahoo.com logoARADIGM CORP Financials (NASDAQ:ARDM)
finance.yahoo.com - December 8 at 1:17 PM
finance.yahoo.com logoHow it All Plays Out - Research on Aradigm, Ideal Power, CareDx, and Colony Bankcorp (NASDAQ:ARDM)
finance.yahoo.com - December 3 at 8:40 AM
biz.yahoo.com logoARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:ARDM)
biz.yahoo.com - November 12 at 3:20 PM
biz.yahoo.com logoARADIGM CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:ARDM)
biz.yahoo.com - November 12 at 6:12 AM
noodls.com logoAradigm Announces Third Quarter 2015 Financial Results (NASDAQ:ARDM)
www.noodls.com - November 11 at 7:16 AM
sg.finance.yahoo.com logoAradigm reports 3Q loss (NASDAQ:ARDM)
sg.finance.yahoo.com - November 11 at 7:06 AM
capitalcube.com logoAradigm Corp. – Value Analysis (NASDAQ:ARDM) : October 30, 2015 (NASDAQ:ARDM)
www.capitalcube.com - October 30 at 3:19 PM
finance.yahoo.com logoAradigm Corporation Completes Enrollment in the Second Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis (ORBIT-3) (NASDAQ:ARDM)
finance.yahoo.com - October 13 at 7:00 AM
noodls.com logoAradigm to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29 (NASDAQ:ARDM)
www.noodls.com - September 23 at 7:25 AM

Social

Aradigm Corp. (NASDAQ:ARDM) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff